Defining the chemokine basis for leukocyte recruitment during viral encephalitis

Journal of Virology

Volumn 88, Issue 17, 2014, Pages 9553-9567

  Michlmayr, Daniela ^a   McKimmie, Clive S ^a   Pingen, Marieke ^a   Haxton, Ben ^b   Mansfield, Karen ^b   Johnson, Nicholas ^b   Fooks, Anthony R ^b   Graham, Gerard J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

ALPHAVIRUS INFECTION; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; FEMALE; IMMUNOLOGY; LEUKOCYTE; PATHOLOGY; SECRETION (PROCESS); SEMLIKI FOREST VIRUS; SURVIVAL; VIROLOGY; VIRUS ENCEPHALITIS; VIRUS LOAD; WEST NILE FEVER; WEST NILE VIRUS;

ALPHAVIRUS INFECTIONS; ANIMALS; BRAIN; CHEMOKINES; DISEASE MODELS, ANIMAL; ENCEPHALITIS, VIRAL; FEMALE; LEUKOCYTES; MICE, INBRED C57BL; RECEPTORS, CHEMOKINE; SEMLIKI FOREST VIRUS; SURVIVAL ANALYSIS; VIRAL LOAD; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84907645907     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03421-13     Document Type: Article

References (59)

1. Ransohoff RM, Engelhardt B. 2012. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12:623-635. http://dx.doi.org/10.1038/nri3265.
2. Kivisakk P, Mahad DJ, Callahan MK, Trebst C, Tucky B, Wei T, Wu LJ, Baekkevold ES, Lassmann H, Staugaitis SM, Campbell JJ, Ransohoff RM. 2003. Human cerebrospinal fluid central memory CD4( ) T cells: evidence for trafficking through choroid plexus and meninges via Pselectin. Proc. Natl. Acad. Sci. U. S. A. 100:8389-8394. http://dx.doi.org/10.1073/pnas.1433000100.
3. Fazakerley JK. 2002. Pathogenesis of Semliki Forest virus encephalitis. J. Neurovirol. 8:66-74. http://dx.doi.org/10.1080/135502802901068000.
4. Griffin DE. 2003. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol. 3:493-502. http://dx.doi.org/10.1038/nri1105.
5. Lane TE, Liu MT, Chen BP, Asensio VC, Samawi RM, Paoletti AD, Campbell IL, Kunkel SL, Fox HS, Buchmeier MJ. 2000. A central role for CD4( ) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J. Virol. 74:1415-1424. http://dx.doi.org/10.1128/JVI.74.3.1415-1424.2000.
6. Suthar MS, Diamond MS, Gale M, Jr. 2013. West Nile virus infection and immunity. Nat. Rev. Microbiol. 11:115-128. http://dx.doi.org/10.1038/nrmicro2950.
7. Mantovani A. 1999. The chemokine system: redundancy for robust outputs. Immunol. Today 20:254-257. http://dx.doi.org/10.1016/S0167-5699(99)01469-3.
8. Rot A, von Andrian UH. 2004. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22:891-928. http://dx.doi.org/10.1146/annurev.immunol.22.012703.104543.
9. Zlotnik A, Yoshie O. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121-127. http://dx.doi.org/10.1016/S1074-7613(00)80165-X.
10. Graham GJ, Locati M. 2013. Regulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6. J. Pathol. 229: 168-175. http://dx.doi.org/10.1002/path.4123.
11. Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, Horuk R, Sparre-Ulrich AH, Locati M, Luster AD, Mantovani A, Matsushima K, Murphy PM, Nibbs R, Nomiyama H, Power CA, Proudfoot AE, Rosenkilde MM, Rot A, Sozzani S, Thelen M, Yoshie O, Zlotnik A. 2014. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol. Rev. 66:1-79. http://dx.doi.org/10.1124/pr.113.007724.
12. McKimmie CS, Graham GJ. 2010. Astrocytes modulate the chemokine network in a pathogen-specific manner. Biochem. Biophys. Res. Commun. 394:1006-1011. http://dx.doi.org/10.1016/j.bbrc.2010.03.111.
13. McKimmie CS, Roy D, Forster T, Fazakerley JK. 2006. Innate immune response gene expression profiles of N9 microglia are pathogen-type specific. J. Neuroimmunol. 175:128-141. http://dx.doi.org/10.1016/j.jneuroim.2006.03.012.
14. Ambrosini E, Aloisi F. 2004. Chemokines and glial cells: a complex network in the central nervous system. Neurochem. Res. 29:1017-1038. http://dx.doi.org/10.1023/B:NERE.0000021246.96864.89.
15. Hesselgesser J, Horuk R. 1999. Chemokine and chemokine receptor expression in the central nervous system. J. Neurovirol. 5:13-26. http://dx.doi.org/10.3109/13550289909029741.
16. Hofer MJ, Carter SL, Mueller M, Campbell IL. 2008. Unaltered neurological disease and mortality in CXCR3-deficient mice infected intracranially with lymphocytic choriomeningitis virus-Armstrong. Viral Immunol. 21:425-433. http://dx.doi.org/10.1089/vim.2008.0057.
17. Zhang B, Chan YK, Lu B, Diamond MS, Klein RS. 2008. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J. Immunol. 180:2641-2649. http://dx.doi.org/10.4049/jimmunol.180.4.2641.
18. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, Pape J, Cheshier RC, Murphy PM. 2006. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 203:35-40. http://dx.doi.org/10.1084/jem.20051970.
19. Lim JK, Glass WG, McDermott DH, Murphy PM. 2006. CCR5: no longer a "good for nothing" gene-chemokine control of West Nile virus infection. Trends Immunol. 27:308-312. http://dx.doi.org/10.1016/j.it.2006.05.007.
20. Nansen A, Christensen JP, Andreasen SO, Bartholdy C, Christensen JE, Thomsen AR. 2002. The role of CC chemokine receptor 5 in antiviral immunity. Blood 99:1237-1245. http://dx.doi.org/10.1182/blood.V99.4.1237.
21. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS. 2005. Neuronal CXCL10 directs CD8( ) T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 79:11457-11466. http://dx.doi.org/10.1128/JVI.79.17.11457-11466.2005.
22. Samuel MA, Diamond MS. 2005. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 79:13350-13361. http://dx.doi.org/10.1128/JVI.79.21.13350-13361.2005.
23. Shrestha B, Wang T, Samuel MA, Whitby K, Craft J, Fikrig E, Diamond MS. 2006. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J. Virol. 80:5338-5348. http://dx.doi.org/10.1128/JVI.00274-06.
24. McKimmie CS, Fraser AR, Hansell C, Gutierrez L, Philipsen S, Connell L, Rot A, Kurowska-Stolarska M, Carreno P, Pruenster M, Chu CC, Lombardi G, Halsey C, McInnes IB, Liew FY, Nibbs RJ, Graham GJ. 2008. Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J. Immunol. 181:3353-3363. http://dx.doi.org/10.4049/jimmunol.181.5.3353.
25. McKimmie CS, Moore M, Fraser AR, Jamieson T, Xu D, Burt C, Pitman NI, Nibbs RJ, McInnes IB, Liew FY, Graham GJ. 2009. A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration. Blood 113:4224-4231. http://dx.doi.org/10.1182/blood-2008-08-174698.
26. McKimmie CS, Fazakerley JK. 2005. In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression. J. Neuroimmunol. 169:116-125. http://dx.doi.org/10.1016/j.jneuroim.2005.08.006.
27. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C-T method. Nat. Protoc. 3:1101-1108. http://dx.doi.org/10.1038/nprot.2008.73.
28. Cardona AE, Huang D, Sasse ME, Ransohoff RM. 2006. Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat. Protoc. 1:1947-1951. http://dx.doi.org/10.1038/nprot.2006.327.
29. Lee KM, McKimmie CS, Gilchrist DS, Pallas KJ, Nibbs RJ, Garside P, McDonald V, Jenkins C, Ransohoff R, Liu L, Milling S, Cerovic V, Graham GJ. 2011. D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood 118:6220-6229. http://dx.doi.org/10.1182/blood-2011-03-344044.
30. Mirzadegan T, Diehl F, Ebi B, Bhakta S, Polsky I, McCarley D, Mulkins M, Weatherhead GS, Lapierre JM, Dankwardt J, Morgans D, Jr, Wilhelm R, Jarnagin K. 2000. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle. J. Biol. Chem. 275: 25562-25571. http://dx.doi.org/10.1074/jbc.M000692200.
31. Du X, Gustin DJ, Chen X, Duquette J, McGee LR, Wang Z, Ebsworth K, Henne K, Lemon B, Ma J, Miao S, Sabalan E, Sullivan TJ, Tonn G, Collins TL, Medina JC. 2009. Imidazo-pyrazine derivatives as potent CXCR3 antagonists. Bioorg. Med. Chem. Lett. 19:5200-5204. http://dx.doi.org/10.1016/j.bmcl.2009.07.021.
32. Johnson M, Li A-R, Liu J, Fu Z, Zhu L, Miao S, Wang X, Xu Q, Huang A, Marcus A, Xu F, Ebsworth K, Sablan E, Danao J, Kumer J, Dairaghi D, Lawrence C, Sullivan T, Tonn G, Schall T, Collins T, Medina J. 2007. Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3. Bioorg. Med. Chem. Lett. 17:3339-3343. http://dx.doi.org/10.1016/j.bmcl.2007.03.106.
33. Lee YK, Choi D-Y, Jung Y-Y, Yun YW, Lee BJ, Han SB, Hong JT. 2013. Decreased pain responses of C-C chemokine receptor 5 knockout mice to chemical or inflammatory stimuli. Neuropharmacology 67:57-65. http://dx.doi.org/10.1016/j.neuropharm.2012.10.030.
34. Rosi S, Pert CB, Ruff MR, McGann-Gramling K, Wenk GL. 2005. Chemokine receptor 5 antagonist d-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease. Neuroscience 134:671-676. http://dx.doi.org/10.1016/j.neuroscience.2005.04.029.
35. Polianova MT, Ruscetti FW, Pert CB, Ruff MR. 2005. Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA). Antiviral Res. 67:83-92. http://dx.doi.org/10.1016/j.antiviral.2005.03.007.
36. Bridge TP, Heseltine PR, Parker E, Eaton E, Ingraham L, Gill M, Ruff M, Pert C, Goodwin F. 1989. Improvement in AIDS patients on peptide T. Lancet ii:226-227.
37. McCandless E, Zhang B, Diamond M, Klein R. 2008. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc. Natl. Acad. Sci. U. S. A. 105:11270-11275. http://dx.doi.org/10.1073/pnas.0800898105.
38. Geissmann F, Jung S, Littman DR. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82. http://dx.doi.org/10.1016/S1074-7613(03)00174-2.
39. Mack M, Cihak J, Simonis C, Luckow B, Proudfoot AEI, Plachý J, Brühl H, Frink M, Anders H-J, Vielhauer V, Pfirstinger J, Stangassinger M, Schlöndorff D. 2001. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166:4697-4704. http://dx.doi.org/10.4049/jimmunol.166.7.4697.
40. Getts D, Terry R, Getts M, Muller M, Rana S, Shrestha B, Radford J, Van Rooijen N, Campbell I, King N. 2008. Ly6c "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J. Exp. Med. 205:2319-2337. http://dx.doi.org/10.1084/jem.20080421.
41. Lim JK, Obara CJ, Rivollier A, Pletnev AG, Kelsall BL, Murphy PM. 2011. Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis. J. Immunol. 186:471-478. http://dx.doi.org/10.4049/jimmunol.1003003.
42. Rosler A, Pohl M, Braune HJ, Oertel WH, Gemsa D, Sprenger H. 1998. Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis. J. Neurol. Sci. 157:82-89. http://dx.doi.org/10.1016/S0022-510X(98)00061-6.
43. Tigabu B, Juelich T, Holbrook MR. 2010. Comparative analysis of immune responses to Russian spring-summer encephalitis and Omsk hemorrhagic fever viruses in mouse models. Virology 408:57-63. http://dx.doi.org/10.1016/j.virol.2010.08.021.
44. Hicks DJ, Núñez A, Banyard AC, Williams A, Ortiz-Pelaez A, Fooks AR, Johnson N. 2013. Differential chemokine responses in the murine brain following lyssavirus Infection. J. Comp. Pathol. 149:446-462. http://dx.doi.org/10.1016/j.jcpa.2013.04.001.
45. Chen B, Kuziel W, Lane T. 2001. Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J. Immunol. 167: 4585-4592. http://dx.doi.org/10.4049/jimmunol.167.8.4585.
46. Glass WG, Chen BP, Liu MT, Lane TE. 2002. Mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease. Viral Immunol. 15:261-272. http://dx.doi.org/10.1089/08828240260066215.
47. Terry R, Getts D, Deffrasnes C, van Vreden C, Campbell I, King N. 2012. Inflammatory monocytes and the pathogenesis of viral encephalitis. J. Neuroinflamm. 9:270. http://dx.doi.org/10.1186/1742-2094-9-270.
48. Klein RS, Diamond MS. 2008. Immunological headgear: antiviral immune responses protect against neuroinvasive West Nile virus. Trends Mol. Med. 14:286-294. http://dx.doi.org/10.1016/j.molmed.2008.05.004.
49. Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou C-L, Ransohoff RM, Charo IF. 2010. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One 5:e13693. http://dx.doi.org/10.1371/journal.pone.0013693.
50. Christensen JE, Simonsen S, Fenger C, Sorensen MR, Moos T, Christensen JP, Finsen B, Thomsen AR. 2009. Fulminant lymphocytic choriomeningitis virus-induced inflammation of the CNS involves a cytokinechemokine-cytokine-chemokine cascade. J. Immunol. 182:1079-1087. http://dx.doi.org/10.4049/jimmunol.182.2.1079.
51. Amor S, Scallan MF, Morris MM, Dyson H, Fazakerley JK. 1996. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. J. Gen. Virol. 77:281-291. http://dx.doi.org/10.1099/0022-1317-77-2-281.
52. Griffin DE. 2010. Recovery from viral encephalomyelitis: immunemediated noncytolytic virus clearance from neurons. Immunol. Res. 47: 123-133. http://dx.doi.org/10.1007/s12026-009-8143-4.
53. Metcalf TU, Griffin DE. 2011. Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system. J. Virol. 85:11490-11501. http://dx.doi.org/10.1128/JVI.05379-11.
54. Subaksharpe I, Dyson H, Fazakerley J. 1993. In vivo depletion of CD8 T-cells prevents lesions of demyelination in Semliki Forest virus infection. J. Virol. 67:7629-7633.
55. Glass WG, Lane TE. 2003. Functional expression of chemokine receptor CCR5 on CD4( ) T cells during virus-induced central nervous system disease. J. Virol. 77:191-198. http://dx.doi.org/10.1128/JVI.77.1.191-198.2003.
56. Berger EA, Murphy PM, Farber JM. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700. http://dx.doi.org/10.1146/annurev.immunol.17.1.657.
57. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM. 2005. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 202:1087-1098. http://dx.doi.org/10.1084/jem.20042530.
58. Horuk R. 2009. Chemokine receptor antagonists: overcoming developmental hurdles. Nat. Rev. Drug Discov. 8:23-33. http://dx.doi.org/10.1038/nrd2734.
59. Schall TJ, Proudfoot AEI. 2011. Overcoming hurdles in developing successful drugs targeting chemokine receptors. Nat. Rev. Immunol. 11:355-363. http://dx.doi.org/10.1038/nri2972.